Literature DB >> 24457561

In brief: ponatinib (Inclusig) returns.

.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 24457561

Source DB:  PubMed          Journal:  Med Lett Drugs Ther        ISSN： 0025-732X            Impact factor:   1.909


× No keyword cloud information.
  2 in total

Review 1.  Clinical advances in the management of chronic myelogenous leukemia: focus on bosutinib and patient considerations.

Authors:  Kendra Sweet; Javier Pinilla-Ibarz; Ling Zhang
Journal:  Patient Prefer Adherence       Date:  2014-07-08       Impact factor: 2.711

2.  BCR-ABL tyrosine kinase inhibitors promote pathological changes in dilator phenotype in the human microvasculature.

Authors:  Matthew J Durand; Shelby N Hader; Alexa Derayunan; Natalya Zinkevich; Jennifer J McIntosh; Andreas M Beyer
Journal:  Microcirculation       Date:  2020-09-05       Impact factor: 2.628
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.